Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Leukemia & Lymphoma
|
October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature review
Iuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
Harsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
JAMA Network Open
|
February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to Myeloma
Lawrence Liu, Nikhil Grandhi, Mei Wang, et al.
Journal of the National Cancer Institute
|
November 9, 2025
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
Maria Mainou, Muatassem Alsadhan, Kalliopi Tsapa, et al.
Haematologica
|
September 2, 2024
Comparing the clinical trial efficacy <i>versus</i> real-world effectiveness of treatments for multiple myeloma: a population-based study
Alissa Visram, Kelvin Kar-Wing Chan, Hsien Seow, et al.
Bone Marrow Transplantation
|
December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
Iuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 24, 2018
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia
Alissa Visram, Joseph Aziz, Adam Bryant, et al.
Blood Cancer Journal
|
August 29, 2025
Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
Adrian Wong, Victor H Jimenez-Zepeda, Kathryn Rankin, et al.
Blood Advances
|
March 22, 2022
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
Celine M Vachon, Josiah Murray, Cristine Allmer, et al.
Leukemia
|
April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100
Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Leukemia & Lymphoma
|
October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature review
Iuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Transplantation and Cellular Therapy
|
April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
Harsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
JAMA Network Open
|
February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to Myeloma
Lawrence Liu, Nikhil Grandhi, Mei Wang, et al.
Journal of the National Cancer Institute
|
November 9, 2025
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
Maria Mainou, Muatassem Alsadhan, Kalliopi Tsapa, et al.
Haematologica
|
September 2, 2024
Comparing the clinical trial efficacy <i>versus</i> real-world effectiveness of treatments for multiple myeloma: a population-based study
Alissa Visram, Kelvin Kar-Wing Chan, Hsien Seow, et al.
Bone Marrow Transplantation
|
December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
Iuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 24, 2018
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia
Alissa Visram, Joseph Aziz, Adam Bryant, et al.
Blood Cancer Journal
|
August 29, 2025
Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
Adrian Wong, Victor H Jimenez-Zepeda, Kathryn Rankin, et al.
Blood Advances
|
March 22, 2022
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
Celine M Vachon, Josiah Murray, Cristine Allmer, et al.
Leukemia
|
April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100
Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Page
of 8